Gian Luca Baiocchi1,2, Simone Giacopuzzi3, Daniele Marrelli4, Daniel Reim5, Guillaume Piessen6, Paulo Matos da Costa7,8, John V Reynolds9, Hans-Joachim Meyer10, Paolo Morgagni11, Ines Gockel12, Lucio Lara Santos13, Lone Susanne Jensen14, Thomas Murphy15, Shaun R Preston16, Mikhail Ter-Ovanesov17, Uberto Fumagalli Romario18, Maurizio Degiuli19, Wojciech Kielan20, Stefan Mönig21, Piotr Kołodziejczyk22, Wojciech Polkowski23, Richard Hardwick24, Manuel Pera25, Jan Johansson26, Paul M Schneider27, Wobbe O de Steur28, Suzanne S Gisbertz29, Henk Hartgrink28, Joanna W van Sandick30, Nazario Portolani31,32, Arnulf H Hölscher33, Maristella Botticini34, Franco Roviello4, Christophe Mariette6, William Allum35, Giovanni De Manzoni3. 1. Department of Clinical and Experimental Sciences, Surgical Clinic, University of Brescia, Brescia, Italy. gianluca.baiocchi@unibs.it. 2. 3rd Division of General Surgery, Spedali Civili di Brescia, P.le Spedali Civili 1, 25127, Brescia, Italy. gianluca.baiocchi@unibs.it. 3. Department of Surgery, General and Upper G.I. Surgery Division, University of Verona, Verona, Italy. 4. Department of Medicine, Surgery and Neurosciences, Unit of General Surgery and Surgical Oncology, University of Siena, Siena, Italy. 5. Surgical Department, Klinikum Rechts der Isar, Technical University Munich, Munich, Germany. 6. Department of Digestive and Oncological Surgery, Univ. Lille, and Claude Huriez University Hospital, Lille, France. 7. Faculdade Medicina, Universidade Lisboa, Lisbon, Portugal. 8. General Surgery Department, Hospital Garcia de Orta, Lisbon, Portugal. 9. Department of Surgery, St. James's Hospital and Trinity College Dublin, Dublin, Ireland. 10. Generalsekretär, Deutsche Gesellschaft für Chirurgie, Berlin, Germany. 11. GB Morgagni-L Pierantoni Surgical Department, Forlì, Italy. 12. Department of Visceral, Transplant, Thoracic and Vascular Surgery, University Hospital of Leipzig, Leipzig, Germany. 13. Experimental Pathology and Therapeutics Group and Surgical Oncology Department, Portuguese Institute of Oncology, Porto, Portugal. 14. Department of Surgery, Aarhus University Hospital, Aarhus C, Denmark. 15. Department of Surgery, Mercy University Hospital, Cork City, Ireland. 16. Oesophageal Gastric Unit, Royal Surrey County Hospital NHS Foundation Trust, Guilford, UK. 17. Oncological and Haematological RUPF, Moscow Municipal Oncological Hospital, Moscow, Russia. 18. 2nd Division of General Surgery, Spedali Civili, Brescia, Italy. 19. Department of Oncology, Head, Digestive and Surgical Oncology, University of Torino, and San Luigi University Hospital, Orbassano, Italy. 20. 2nd Department of General and Oncological Surgery, Wroclaw Medical University, Wrocław, Poland. 21. Division of Abdominal Surgery, University Hospital of Geneva, Geneva, Switzerland. 22. Department of Surgery I, Jagiellonian University, Krakow, Poland. 23. Department of Surgical Oncology, Medical University of Lublin, Lublin, Poland. 24. Spire Cambridge Lea Hospital, Cambridge, UK. 25. Department of Surgery, Section of Gastrointestinal Surgery, Hospital Universitario del Mar, Universitat Autònoma de Barcelona, and Hospital Universitario del Mar Medical Research Institute (IMIM), Barcelona, Spain. 26. Department of Clinical Sciences, Surgery, Faculty of Medicine, Lund University, Lund, Sweden. 27. Center for Visceral, Thoracic and Specialized Tumor Surgery, Hirslanden Medical Center, Zurich, Switzerland. 28. Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands. 29. Department of Surgery, Academic Medical Center, Amsterdam, The Netherlands. 30. Department of Surgery, Netherlands Cancer Institute, and Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. 31. Department of Clinical and Experimental Sciences, Surgical Clinic, University of Brescia, Brescia, Italy. 32. 3rd Division of General Surgery, Spedali Civili di Brescia, P.le Spedali Civili 1, 25127, Brescia, Italy. 33. German Center for Esophageal and Gastric Surgery, Agaplesion Markuskrankenhaus, Frankfurt, Germany. 34. IGIER, Università Bocconi, Milan, Italy. 35. Department of Surgery, Royal Marsden NHS Foundation Trust, London, UK.
Abstract
BACKGROUND: Perioperative complications can affect outcomes after gastrectomy for cancer, with high mortality and morbidity rates ranging between 10 and 40%. The absence of a standardized system for recording complications generates wide variation in evaluating their impacts on outcomes and hinders proposals of quality-improvement projects. The aim of this study was to provide a list of defined gastrectomy complications approved through international consensus. METHODS: The Gastrectomy Complications Consensus Group consists of 34 European gastric cancer experts who are members of the International Gastric Cancer Association. A group meeting established the work plan for study implementation through Delphi surveys. A consensus was reached regarding a set of standardized methods to define gastrectomy complications. RESULTS: A standardized list of 27 defined complications (grouped into 3 intraoperative, 14 postoperative general, and 10 postoperative surgical complications) was created to provide a simple but accurate template for recording individual gastrectomy complications. A consensus was reached for both the list of complications that should be considered major adverse events after gastrectomy for cancer and their specific definitions. The study group also agreed that an assessment of each surgical case should be completed at patient discharge and 90 days postoperatively using a Complication Recording Sheet. CONCLUSION: The list of defined complications (soon to be validated in an international multicenter study) and the ongoing development of an electronic datasheet app to record them provide the basic infrastructure to reach the ultimate goals of standardized international data collection, establishment of benchmark results, and fostering of quality-improvement projects.
BACKGROUND: Perioperative complications can affect outcomes after gastrectomy for cancer, with high mortality and morbidity rates ranging between 10 and 40%. The absence of a standardized system for recording complications generates wide variation in evaluating their impacts on outcomes and hinders proposals of quality-improvement projects. The aim of this study was to provide a list of defined gastrectomy complications approved through international consensus. METHODS: The Gastrectomy Complications Consensus Group consists of 34 European gastric cancer experts who are members of the International Gastric Cancer Association. A group meeting established the work plan for study implementation through Delphi surveys. A consensus was reached regarding a set of standardized methods to define gastrectomy complications. RESULTS: A standardized list of 27 defined complications (grouped into 3 intraoperative, 14 postoperative general, and 10 postoperative surgical complications) was created to provide a simple but accurate template for recording individual gastrectomy complications. A consensus was reached for both the list of complications that should be considered major adverse events after gastrectomy for cancer and their specific definitions. The study group also agreed that an assessment of each surgical case should be completed at patient discharge and 90 days postoperatively using a Complication Recording Sheet. CONCLUSION: The list of defined complications (soon to be validated in an international multicenter study) and the ongoing development of an electronic datasheet app to record them provide the basic infrastructure to reach the ultimate goals of standardized international data collection, establishment of benchmark results, and fostering of quality-improvement projects.
Authors: Pietro Maria Lombardi; Michele Mazzola; Alessandro Giani; Sara Baleri; Marianna Maspero; Paolo De Martini; Monica Gualtierotti; Giovanni Ferrari Journal: Updates Surg Date: 2021-05-20
Authors: Timo Niels; Christoph T Baltin; Guido Kosanke; Ulrich K Fetzner; Arnulf H Hoelscher; Elfriede Bollschweiler; Jan-Hendrik Naendrup; Freerk T Baumann Journal: In Vivo Date: 2022 Jul-Aug Impact factor: 2.406
Authors: Karol Rawicz-Pruszyński; Katarzyna Sędłak; Radosław Mlak; Jerzy Mielko; Wojciech P Polkowski Journal: Cancers (Basel) Date: 2020-06-26 Impact factor: 6.639
Authors: W H Allum; E C Smyth; J M Blazeby; H I Grabsch; S M Griffin; S Rowley; F H Cafferty; R E Langley; D Cunningham Journal: Br J Surg Date: 2019-07-03 Impact factor: 6.939
Authors: Enrique Norero; Jose Luis Quezada; Jaime Cerda; Marco Ceroni; Cristian Martinez; Ricardo Mejía; Rodrigo Muñoz; Fernando Araos; Paulina González; Alfonso Díaz Journal: Arq Bras Cir Dig Date: 2019-12-20
Authors: Paula R Williamson; Iain A Bruce; Bilal Alkhaffaf; Jane M Blazeby; Aleksandra Metryka; Anne-Marie Glenny; Ademola Adeyeye; Paulo Matos Costa; Ismael Diez Del Val; Suzanne S Gisbertz; Ali Guner; Simon Law; Hyuk-Joon Lee; Ziyu Li; Koji Nakada; Rafael Mauricio Restrepo Nuñez; Daniel Reim; John V Reynolds; Peter Vorwald; Daniela Zanotti; William Allum; M Asif Chaudry; Ewen Griffiths Journal: Trials Date: 2021-06-21 Impact factor: 2.279
Authors: Uberto Fumagalli; Gian Luca Baiocchi; Andrea Celotti; Paolo Parise; Andrea Cossu; Luigi Bonavina; Daniele Bernardi; Giovanni de Manzoni; Jacopo Weindelmayer; Giuseppe Verlato; Stefano Santi; Giovanni Pallabazzer; Nazario Portolani; Maurizio Degiuli; Rossella Reddavid; Stefano de Pascale Journal: World J Gastroenterol Date: 2019-01-21 Impact factor: 5.742